Showing results (1-10 of 2,534) with videos related to

Sort By:
Pageof 254
The Psychiatric Clinics of North America|June 1, 1993
Predictors of response to neuroleptic treatment in schizophreniaR G Stern, R S Kahn, M Davidson
The American Journal of Psychiatry|November 1, 1991
Dopamine in schizophrenia: a review and reconceptualizationK L Davis, R S Kahn, G Ko, et al.
Psychopharmacology|January 1, 1993
Haloperidol and clozapine treatment and their effect on M-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapineR S Kahn, L Siever, M Davidson, et al.
Biological Psychiatry|December 1, 1992
Effect of m-chlorophenylpiperazine on plasma homovanillic acid concentrations in healthy subjectsR S Kahn, P Knott, S Gabriel, et al.
Biological Psychiatry|June 15, 1994
Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazineR S Kahn, M Davidson, L J Siever, et al.
Psychopharmacology|February 1, 1994
Effects of ipsapirone in healthy subjects: a dose-response studyR S Kahn, R Trestman, B A Lawlor, et al.
The American Journal of Psychiatry|December 1, 1994
Early response to clozapine in schizophreniaR G Stern, R S Kahn, M Davidson, et al.
The American Journal of Psychiatry|September 1, 1993
Serotonin function and treatment response to clozapine in schizophrenic patientsR S Kahn, M Davidson, L Siever, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 24, 1998
Control of renal factors in plasma homovanillic acid measurementsF Amin, A E Stroe, T Kahn, et al.
Archives of General Psychiatry|August 1, 1993
Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatmentR S Kahn, M Davidson, P Knott, et al.
Pageof 254